Proven engine, fuel already in the tank: a working growth driver plus already-held means to multiply it
The model's full reasoning — Q2 2023 call → NOWe need to determine if management describes both (1) a proven, already-producing growth engine that is still small relative to its room, and (2) the means to multiply it are already in the company's hands, all about the same part of the business, as one connected present-tense story. Let's analyze the transcript. Management discusses several growth drivers: PhenoCycler-Fusion, PhenoImager HT, reagent panels (Discovery panels and Signature panels), services (CLIA lab, ABS, Acrivon partnership), etc. We need to find a specific driver that is already generating real business, is still small relative to its potential, and the company already has the means to scale it up. Look for statements about reagent revenue, pull-through, installed base, etc. Brian mentions: "We continue to see robust growth in the translational markets with growing momentum within our biopharma and CRO partners as they leverage the PhenoImager HT platform to address their growing biomarker needs, especially in oncology and immunotherapy applications." He talks about the PhenoImager HT and the signature panels. He says: "The signature panels for the HT are designed to enable fast and scalable assay development and deployment for large immuno-oncology translational biomarker studies, resulting in accelerated HT utilization and an increased ASP percent." Later, in response to a question about which new product launches will be material, Brian says: "I think for me, as we get towards the end of '23 and into '24, I really think it's the signature panels on the HT... I think those have an opportunity to be material because the way those go, Mark, is there's a limited evaluation, and there's a bit of a validation period with our biopharma partners and CROs, and then they get to full implementation at scale. These are being evaluated for larger-scale projects. So, that's the one I look at -- that's the product line I look at to have more like a step function impact then something like the 2.0 where you have kind of a gradual roll in over time." This suggests that the signature panels are still in evaluation/validation phase, not yet generating significant revenue. So that might not be "already-producing" yet. What about the PhenoCycler-Fusion? Brian says: "The Fusion 2.0 instrument hardware and software field upgrade was initiated as of the second quarter.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| NOAH | Noah Holdings Limited | Q1 2024 | 2024-05-30 | D |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| ROCK | Gibraltar Industries, Inc. | Q1 2024 | 2024-05-01 | B+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| TNET | TriNet Group, Inc. | Q1 2024 | 2024-04-26 | C |
| APYX | Apyx Medical Corporation | Q4 2023 | 2024-03-21 | C |
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| OUT | Outfront Media Inc. | Q4 2023 | 2024-02-21 | C+ |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| APAM | Artisan Partners Asset Management Inc. | Q3 2023 | 2023-11-01 | C+ |
| RVLV | Revolve Group, Inc. | Q3 2023 | 2023-11-01 | C |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| FSBC | Five Star Bancorp | Q3 2023 | 2023-10-31 | B |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| PTLO | Portillo's Inc. | Q2 2023 | 2023-08-05 | B |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| NMR | Nomura Holdings, Inc. | Q1 2024 | 2023-08-02 | D |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| M | Macy's, Inc. | Q4 2022 | 2023-03-02 | D |
| TGT | Target Corporation | Q4 2022 | 2023-02-28 | C |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| HBAN | Huntington Bancshares Incorporated | Q4 2022 | 2023-01-20 | B |
| WGO | Winnebago Industries, Inc. | Q1 2023 | 2022-12-16 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| KEY | KeyCorp | Q3 2022 | 2022-10-20 | B+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| HLNE | Hamilton Lane Incorporated | Q1 2023 | 2022-08-02 | C+ |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| UPWK | Upwork Inc. | Q2 2022 | 2022-07-27 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| SE | Sea Limited | Q1 2022 | 2022-05-17 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| VVV | Valvoline Inc. | Q1 2022 | 2022-02-09 | C+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| LOW | Lowe's Companies, Inc. | Q3 2021 | 2021-11-17 | B+ |
| KTB | Kontoor Brands, Inc. | Q3 2021 | 2021-11-04 | A |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| CPRX | Catalyst Pharmaceuticals, Inc. | Q2 2021 | 2021-08-10 | C+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| EEX | Emerald Holding, Inc. | Q2 2021 | 2021-08-01 | C+ |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
| TENB | Tenable Holdings, Inc. | Q2 2021 | 2021-07-27 | A |
| JPM | JPMorgan Chase & Co. | Q2 2021 | 2021-07-13 | A |
| CMTL | Comtech Telecommunications Corp. | Q1 2019 | 2018-12-07 | B+ |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| AMGN | Amgen Inc. | Q3 2018 | 2018-10-30 | B+ |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| STM | STMicroelectronics NV | Q3 2018 | 2018-10-24 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| LAUR | Laureate Education, Inc. | Q1 2018 | 2018-05-13 | B+ |
| NOVT | Novanta Inc. | Q4 2017 | 2018-05-12 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| UPLD | Upland Software, Inc. | Q4 2017 | 2018-03-08 | C+ |
| FI | Fiserv, Inc. | Q4 2017 | 2018-02-27 | C |
| UNH | UnitedHealth Group Incorporated | Q4 2017 | 2018-01-16 | A |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| UAA | Under Armour, Inc. | Q3 2017 | 2017-10-31 | F |
| IR | Ingersoll-Rand Plc | Q3 2017 | 2017-10-25 | B |
| MKTX | MarketAxess Holdings Inc. | Q3 2017 | 2017-10-25 | C+ |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| CCOI | Cogent Communications Holdings, Inc. | Q2 2017 | 2017-08-03 | B |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
| WK | Workiva Inc. | Q4 2015 | 2016-03-01 | B |
NMR · Q1 2024 → YESThe question is whether management describes BOTH a proven, already-producing growth engine that's still small relative to its room, AND the means to multiply it already in the company's hands, as one...YES The transcript shows management describing the Retail business as a growth engine that's already producing real results (net revenue up 22%, income up 133% after reorganization in March, recurring and flow revenue benefits starting to appear) but still small relative to its room (only 1,600 partners deployed out of a much larger potential base, with Q-on-Q progress negative from uncontacted clients, and explicit statements like "if we can broaden our partner base, then we will start to see the benefit" and "we have not been able to contact all clients").
OWL · Q2 2021 → YESThe question is whether management describes BOTH a proven, already-producing growth engine that's still small relative to its room, AND the means to multiply it already in the company's hands, as one...YES The transcript shows management describing Direct Lending as a proven growth engine already producing real activity ($5.1 billion gross deployments in the quarter, $31 billion AUM) while still small relative to its opportunity (explicitly "very small relative to total market opportunity" with a $300 billion market and $1. 5 trillion PE dry powder). They connect this directly to the means already in hand: existing sponsor relationships (500), $8.
WRBY · Q1 2024 → YESThe question is: Does management describe BOTH of a proven, already-producing growth engine that's still small relative to its room, AND the means to multiply it already in the company's hands, as one...